• Profile
Close

A risk score to predict the development of hepatic encephalopathy in a population-based cohort of patients with cirrhosis

Hepatology May 22, 2018

Tapper EB, et al. - A population-based cohort of all patients with cirrhosis without baseline hepatic encephalopathy (HE) from the Veterans Administration from Michigan, Indiana, and Ohio (January 1, 2005-December 31, 2010) using demographic, clinical, laboratory, and pharmacy data was studied to develop a tool to risk-stratify patients for HE development. Results of this study suggested that patients with cirrhosis could be stratified by a simple risk score for HE that accounts for changing clinical data. In addition, the data highlighted a role for statins in decreasing cirrhosis complications including HE.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay